STEM CELL THERAPIES FOR HUNTINGTON?S DISEASE

亨廷顿病的干细胞疗法

• 批准号: 8172613
• 负责人: Jan A. Nolta
• 金额: $ 7.6万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-06-01 至 2011-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8172613
• 关键词: Cell Therapy; Computer Retrieval of Information on Scientific Projects Database; Funding; Goals; Grant; Huntington Disease; Institution; Neurodegenerative Disorders; Patients; Research; Research Personnel; Resources; Source; United States National Institutes of Health; stem cell therapy

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of these studies is to develop new cell-based therapies for patients with Huntington's Disease. Huntington's Disease is a fatal neurodegenerative disorder for which there are currently no cures.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这些研究的目标是为亨廷顿病患者开发新的基于细胞的疗法。亨廷顿氏病是一种致命的神经退行性疾病，目前尚无治愈方法。